Artivion | CRY - 销售毛利

金融业

USD

USD 883.16M

现金及等价物

USD 55.76M

USD 42.85M

USD 357.52M

USD 92.7M

USD 317.78M

USD 4.79M

USD 22.72M

1.5K

EPS每股收益

USD -0.02

股本和储备

USD 450.47M

USD 73.14M

债务利息支出

USD 5.53M

USD -0.05

USD 215.35M

USD 939.9M

USD 2.42M

USD 111.2M

USD 4.79M

普通股股本

USD 47.84M

212.38

USD 11.4M

USD 115.99M

销售和管理费用

USD 55.75M

USD 98M

贸易债权人

USD 18.34M

应收帐款人

USD 103.68M

	销售毛利	更改		日
Abbott	USD 5.86B		675M	2026-03
Accuray	USD 41.89M		7.42M	2024-12
AngioDynamics	USD 44.78M		2.93M	2025-09
Artivion	USD 73.14M		1.25M	2025-12
AtriCure	USD 109.31M		3.97M	2026-03
Baxter International	USD 891M		314M	2026-03
Becton, Dickinson and Co.	USD 2.15B		257M	2026-03
Boston Scientific	USD 3.61B		64M	2026-03
Edwards Lifesciences	USD 1.29B		59.4M	2026-03
Inogen	USD 41.34M		1.39M	2024-09
Integra LifeSciences	USD 213.21M		3.89M	2026-03
J&J	USD 17.24B		642M	2026-03
Mesa Laboratories	USD 39.75M		4.3M	2024-12
Orthofix International	USD 153.28M		4.76M	2025-12
Pfizer	USD 11.04B		1.24B	2026-03
ResMed	USD 890.98M		12.26M	2026-03
Stryker	USD 3.81B		675M	2026-03
Surmodics	USD 20.08M		31.62M	2025-06
Tandem Diabetes Care	USD 167.46M		33.17M	2025-12
Teleflex	USD 307.43M		21K	2026-03
Terumo	JPY 149.02B		4.17B	2026-03
Trinity Biotech	USD 6.47M		1.59M	2025-09